✦ LIBER ✦

Interaction of the Efflux Transporters ABCB1 and ABCG2 With Imatinib, Nilotinib, and Dasatinib

✍ Scribed by Eadie, L N; Hughes, T P; White, D L

Book ID: 124100499
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 492 KB
Volume: 95
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2013.208

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interaction of nilotinib, dasatinib and

Interaction of nilotinib, dasatinib and bosutinib with ABCB1 and ABCG2: implications for altered anti-cancer effects and pharmacological properties

✍ C Hegedűs; C Özvegy-Laczka; Á Apáti; M Magócsi; K Német; L Őrfi; G Kéri; M Katon 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 512 KB

Multispecificity of Drug Transporters: P

Multispecificity of Drug Transporters: Probing Inhibitor Selectivity for the Human Drug Efflux Transporters ABCB1 and ABCG2

✍ Joerg Cramer; Stephan Kopp; Susan E. Bates; Peter Chiba; Gerhard F. Ecker 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

Efflux transporters in ulcerative coliti

Efflux transporters in ulcerative colitis: Decreased expression of BCRP (ABCG2) and Pgp (ABCB1)

✍ Gunilla Englund; Annica Jacobson; Fredrik Rorsman; Per Artursson; Andreas Kindma 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

## Background: Efflux transport proteins are important components of the intestinal barrier against bacterial toxins, carcinogens, and drugs. this investigation was conducted to determine the expression of breast cancer resistance protein (bcrp/abcg2), p-glycoprotein (pgp/mdr1/abcb1), and multidrug

Resistance to daunorubicin, imatinib, or

Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells

✍ Kosztyu, Petr; Bukvova, Romana; Dolezel, Petr; Mlejnek, Petr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 853 KB

Drug interactions with the tyrosine kina

Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib

✍ Haouala, A.; Widmer, N.; Duchosal, M. A.; Montemurro, M.; Buclin, T.; Decosterd, 📂 Article 📅 2011 🏛 American Society of Hematology 🌐 English ⚖ 103 KB

Nilotinib (AMN107, Tasigna®) reverses mu

Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters

✍ Amit K. Tiwari; Kamlesh Sodani; Si-Rong Wang; Ye-Hong Kuang; Charles R. Ashby Jr 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 377 KB